Keywords: cephalon, 3rd-qtr, sales, increases, usa-based, says, its
Cephalon's 3rd-qtr 2006 sales increases 56%
Article | 13 November 2006
USA-based Cephalon says its third-quarter 2006 revenues reached $482.3 million, a 56% surge on the like, year-ago period. Sales during the period, which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
